James Shin
Stock Analyst at Deutsche Bank
(2.79)
# 1,713
Out of 5,241 analysts
25
Total ratings
58.33%
Success rate
26.38%
Average return
Main Sectors:
Top Industries:
Stocks Rated by James Shin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| STRO Sutro Biopharma | Maintains: Buy | $51 → $55 | $34.48 | +59.51% | 2 | Mar 25, 2026 | |
| LLY Eli Lilly and Company | Maintains: Buy | $1,200 → $1,285 | $988.09 | +30.05% | 6 | Feb 9, 2026 | |
| MRK Merck & Co. | Maintains: Hold | $110 → $111 | $112.56 | -1.39% | 3 | Nov 18, 2025 | |
| IMTX Immatics | Initiates: Buy | $10 | $10.62 | -5.84% | 1 | May 28, 2025 | |
| GILD Gilead Sciences | Upgrades: Buy | $80 → $120 | $129.67 | -7.46% | 2 | Feb 18, 2025 | |
| AMGN Amgen | Reiterates: Hold | $310 → $305 | $324.39 | -5.98% | 2 | Aug 7, 2024 | |
| INCY Incyte | Maintains: Hold | $55 → $60 | $95.19 | -36.97% | 2 | Aug 1, 2024 | |
| BMY Bristol-Myers Squibb Company | Maintains: Hold | $53 → $45 | $57.31 | -21.48% | 3 | Jul 23, 2024 | |
| LEGN Legend Biotech | Initiates: Buy | $60 | $26.98 | +122.39% | 1 | May 23, 2024 | |
| ABBV AbbVie | Initiates: Hold | $150 | $209.41 | -28.37% | 1 | Nov 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $800 | $629.68 | +27.05% | 1 | Nov 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $10 | $1.80 | +455.56% | 1 | Nov 9, 2023 |
Sutro Biopharma
Mar 25, 2026
Maintains: Buy
Price Target: $51 → $55
Current: $34.48
Upside: +59.51%
Eli Lilly and Company
Feb 9, 2026
Maintains: Buy
Price Target: $1,200 → $1,285
Current: $988.09
Upside: +30.05%
Merck & Co.
Nov 18, 2025
Maintains: Hold
Price Target: $110 → $111
Current: $112.56
Upside: -1.39%
Immatics
May 28, 2025
Initiates: Buy
Price Target: $10
Current: $10.62
Upside: -5.84%
Gilead Sciences
Feb 18, 2025
Upgrades: Buy
Price Target: $80 → $120
Current: $129.67
Upside: -7.46%
Amgen
Aug 7, 2024
Reiterates: Hold
Price Target: $310 → $305
Current: $324.39
Upside: -5.98%
Incyte
Aug 1, 2024
Maintains: Hold
Price Target: $55 → $60
Current: $95.19
Upside: -36.97%
Bristol-Myers Squibb Company
Jul 23, 2024
Maintains: Hold
Price Target: $53 → $45
Current: $57.31
Upside: -21.48%
Legend Biotech
May 23, 2024
Initiates: Buy
Price Target: $60
Current: $26.98
Upside: +122.39%
AbbVie
Nov 9, 2023
Initiates: Hold
Price Target: $150
Current: $209.41
Upside: -28.37%
Nov 9, 2023
Initiates: Hold
Price Target: $800
Current: $629.68
Upside: +27.05%
Nov 9, 2023
Initiates: Buy
Price Target: $10
Current: $1.80
Upside: +455.56%